Copyright
©The Author(s) 2023.
World J Cardiol. Nov 26, 2023; 15(11): 571-581
Published online Nov 26, 2023. doi: 10.4330/wjc.v15.i11.571
Published online Nov 26, 2023. doi: 10.4330/wjc.v15.i11.571
Figure 1 Schematic representation of the risk factors that contribute to the development of acute coronary syndromes in myelopro liferative neoplasms.
MPNs: Myeloproliferative neoplasms; ACS: Acute coronary syndromes.
Figure 2 Potential biomarkers linking acute coronary syndromes and myeloproliferative neoplasms.
MPNs: Myeloproliferative neoplasms; ACS: Acute coronary syndromes; LDH: Lactate dehydrogenase; CK: Creatine kinase; Tn: Troponin; OS: Oxidative stress; IMA: Ischemia-modified albumin; CRP: C-reactive protein; TNF-alpha: Tumor necrosis factor alpha; IL-6: Interleukin-6; IL-1: Interleukin-1; TG: Triglycerides; LDL-c: Low-density lipoprotein cholesterol; ApoA1: Apolipoprotein A1; CHIP: Clonal hematopoiesis of indeterminate potential.
- Citation: Manan MR, Kipkorir V, Nawaz I, Waithaka MW, Srichawla BS, Găman AM, Diaconu CC, Găman MA. Acute myocardial infarction in myeloproliferative neoplasms. World J Cardiol 2023; 15(11): 571-581
- URL: https://www.wjgnet.com/1949-8462/full/v15/i11/571.htm
- DOI: https://dx.doi.org/10.4330/wjc.v15.i11.571